Citigroup analyst Samantha Semenkow maintains Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy and raises the price target from $27 to $31.
- Headlines
- Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $31
Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $31
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
20:37
STANCHART: Independent non-executive director David Conner will step down as a member of the Board of Directors.
STANCHART+0.93%
20:35
Refusing to hire employees over 35 in Hong Kong? Xiaomi's Wang Hua: Someone is trying to smear Xiaomi.
XIAOMI-W-1.62%
20:34
Tesla's stock price rose 1.5% in pre-market trading.
TSLA+2.87%